Track outcomes after placing or removing an IVC filter
Part of Heart & circulation clinical trials.
This study follows adults who are getting an IVC filter placed or removed. It aims to better understand how patients do after the procedure, both in the short term and longer term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must be scheduled to have an IVC filter placed or removed
- You will be having this procedure as part of routine care or treatment plans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks outcomes and safety using real-world health data from people who received a specific type of vena cava filter. It may help improve future care by understanding how these devices perform after placement.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
This trial compares two different tools for taking out an IVC filter (a device placed in a large vein to help prevent blood clots). It’s meant to find which removal method is safer and works better for eligible adults who just had a specific filter placed.
This study follows people with a blood clot in the calf vein to learn how the clot changes over time using repeat ultrasound scans. It may help doctors understand who needs treatment and who can be watched safely.
This study looks at how often a temporary emergency heart catheter, called a central venous catheter, stays in and causes problems in ICU patients. It may help doctors understand when to remove such catheters.
This study tracks how well the Cleaner Vac® system works to remove blood clots from leg veins over time. It may be an option for people with new or recent deep vein thrombosis (DVT) who are getting their first treatment.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.